[Determination of platelet activating factor in middle ear effusion of patients with secretory oitits media]

Liang Chen1, Yile Huang, Jingmin You

  • 1Department of Otorhinolaryngology, Guangzhou General Hospital of Guangzhou Military Command, Guangzhou 510010.

Lin Chuang Er Bi Yan Hou Ke Za Zhi = Journal of Clinical Otorhinolaryngology
|January 20, 2004
PubMed
Abstract

Insights

Platelet activating factor (PAF) is significantly elevated in middle ear effusion (MEE) of patients with secretory otitis media (SOM). This finding suggests PAF plays a key role in SOM pathogenesis and persistence.

Area of Science:

  • Otolaryngology
  • Immunology
  • Biochemistry

Context:

  • Secretory otitis media (SOM) is a common condition characterized by fluid in the middle ear.
  • The exact mechanisms driving SOM pathogenesis are not fully understood.
  • Platelet activating factor (PAF) is a potent inflammatory mediator.

Purpose:

  • To investigate the role of platelet activating factor (PAF) in the pathogenesis of secretory otitis media (SOM).

Summary:

  • PAF concentrations were measured in blood plasma and middle ear effusion (MEE) of 56 SOM patients and 40 controls using RP-HPLC.
  • PAF levels were significantly higher in MEE compared to blood plasma (P < 0.01).
  • PAF levels in blood plasma were elevated in SOM patients versus controls (P < 0.05), and higher in mucous MEE than serous MEE (P < 0.01).

Impact:

  • PAF may be a crucial mediator in the middle ear effusion of SOM.
  • Elevated PAF levels are potentially linked to the chronicity of SOM.
  • This study highlights PAF's significant role in the development of secretory otitis media.

Related Concept Videos